Experienced in Heart Failure

Zuyi A. Yuan

Key Laboratory Of Environment And Genes Related To Diseases, 
Xi'an, CN 
Experienced in Heart Failure
Key Laboratory Of Environment And Genes Related To Diseases, 
Xi'an, CN 
OverviewLocationsClinical Research

Overview

Zuyi Yuan practices in Xi'an, China. Yuan is rated as an Experienced expert by MediFind in the treatment of Heart Failure. Their top areas of expertise are Atherosclerosis, Coronary Heart Disease, Heart Attack, Percutaneous Coronary Intervention (PCI), and Lithotripsy.

Their clinical research consists of co-authoring 241 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 13 articles in the study of Heart Failure.

Locations

Key Laboratory Of Environment And Genes Related To Diseases, Xi'an, 710061, China
Other Locations
277 West Yanta Road, Xi'an, 710061, China
No. 277 Yanta Xi Street, Xi'an, 710061, China
Yanta West Road, Xi'an, China
No. 277 Yanta West Road, Xi'an, 710061, China
No 1 Jiankang Road, Xi'an, 710061, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Heart Failure With Preserved Ejection Fraction and Obesity (SUMMIT)
Enrollment Status: Completed
Publish Date: August 20, 2025
Intervention Type: Other, Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Prospective, Multi-Center, Single-Arm, Post Market Study of the MitraClip System for the Treatment of Symptomatic Mitral Regurgitation in China
A Prospective, Multi-Center, Single-Arm, Post Market Study of the MitraClip System for the Treatment of Symptomatic Mitral Regurgitation in China
Enrollment Status: Active_not_recruiting
Publish Date: June 21, 2024
Intervention Type: Device
Study Phase: Not Applicable
View 1 Less Clinical Trial

241 Total Publications

Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study).
Safety and Efficacy of Intravascular Lithotripsy System: A Prospective, Multicenter Clinical Trial (The VIGOUR Study).
Journal: Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
Published: August 21, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yuan's expertise for a condition
ConditionClose
      View All 43 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile